Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Workshop Weighs Breast Cancer Ablation Benefits, Trial Protocol Issues

This article was originally published in The Gray Sheet

Executive Summary

Stakeholders debating appropriate feasibility study protocol for image-guided thermal ablation of early-stage breast cancer are cautioning that increased use of advanced imaging for the procedures may counter some of the anticipated cost benefits
Advertisement

Related Content

Frontiers in Breast Cancer Research, Part II: Developments in Partial Breast Irradiation and Tumor Ablation
Consensus Elusive On Design Of Breast Cancer Ablation Registry
Consensus Elusive On Design Of Breast Cancer Ablation Registry
FDA Proposes Registry On Thermal Ablation For Breast Cancer
FDA Proposes Registry On Thermal Ablation For Breast Cancer
FDA Critical Path Office Would Define Up To Four “Opportunities” Per Year
Advertisement
UsernamePublicRestriction

Register

MT026590

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel